Boothbay Fund Management »

CNS Pharmaceuticals shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of CNS Pharmaceuticals (CNSP) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in CNS Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including CNS Pharmaceuticals held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in CNS Pharmaceuticals by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $32k 14k 2.39
2025-12-31 $71k 14k 5.25

More positions owned by Boothbay Fund Management

At&t Call Option (T)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Revolution Medicines Call Option (RVMD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation Put Option (NVDA)
Tesla Motors Call Option (TSLA)
Abivax Sa Sponsored Ads (ABVX)
Ge Aerospace Com New Call Option (GE)
Invesco Exch Traded Fd Tr Ii Kbw Bk Etf Call Option (KBWB)
Microsoft Corporation Put Option (MSFT)
Amazon Call Option (AMZN)
Cornerstone Strategic Value (CLM)
Mineralys Therapeutics Put Option (MLYS)
United Therapeutics Corporation Call Option (UTHR)
Constellation Brands Cl A Call Option (STZ)

View all positions for Boothbay Fund Management

Top funds holding CNS Pharmaceuticals

Stonepine Capital Management
Ikarian Capital
Geode Capital Management
Boothbay Fund Management
UBS Group
Barrett & Company
MAI Wealth Advisors
Citigroup
Caitong International Asset Management
Danske Bank A/s

View all funds holding CNS Pharmaceuticals